BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28214518)

  • 1. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
    Rives ML; Javitch JA; Wickenden AD
    Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Druggability of Solute Carriers.
    Wang WW; Gallo L; Jadhav A; Hawkins R; Parker CG
    J Med Chem; 2020 Apr; 63(8):3834-3867. PubMed ID: 31774679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
    Schlessinger A; Zatorski N; Hutchinson K; Colas C
    Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
    Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
    Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Structure and Mechanism of Drug Transporters.
    Roberts AG
    Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting Cysteine Residues of SLC Membrane Transporters as Targets for Drugs.
    Scalise M; Console L; Galluccio M; Pochini L; Tonazzi A; Giangregorio N; Indiveri C
    SLAS Discov; 2019 Oct; 24(9):867-881. PubMed ID: 31251685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SLC transporter in nutrient and metabolic sensing, regulation, and drug development.
    Zhang Y; Zhang Y; Sun K; Meng Z; Chen L
    J Mol Cell Biol; 2019 Jan; 11(1):1-13. PubMed ID: 30239845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances and Challenges in Rational Drug Design for SLCs.
    Garibsingh RA; Schlessinger A
    Trends Pharmacol Sci; 2019 Oct; 40(10):790-800. PubMed ID: 31519459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent developments in ligands and chemical probes targeting solute carrier transporters.
    Casiraghi A; Bensimon A; Superti-Furga G
    Curr Opin Chem Biol; 2021 Jun; 62():53-63. PubMed ID: 33689964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane transporters in cell physiology, cancer metabolism and drug response.
    Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
    Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of small molecule transporter systems by Transporter-Interfering Chemicals (TICs).
    Nicklisch SCT; Hamdoun A
    FEBS Lett; 2020 Dec; 594(23):4158-4185. PubMed ID: 33222203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TICBase: Integrated Resource for Data on Drug and Environmental Chemical Interactions with Mammalian Drug Transporters.
    Michel ME; Wen CC; Yee SW; Giacomini KM; Hamdoun A; Nicklisch SCT
    Clin Pharmacol Ther; 2023 Dec; 114(6):1293-1303. PubMed ID: 37657924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SLC transporters as therapeutic targets: emerging opportunities.
    Lin L; Yee SW; Kim RB; Giacomini KM
    Nat Rev Drug Discov; 2015 Aug; 14(8):543-60. PubMed ID: 26111766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transporter-Mediated Drug Delivery.
    Gyimesi G; Hediger MA
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Throughput Expression and Purification of Human Solute Carriers for Structural and Biochemical Studies.
    Raturi S; Li H; Chang YN; Scacioc A; Bohstedt T; Fernandez-Cid A; Evans A; Abrusci P; Balakrishnan A; Pascoa TC; He D; Chi G; Kaur Singh N; Ye M; Li A; Shrestha L; Wang D; Williams EP; Burgess-Brown NA; Dürr KL; Puetter V; Ingles-Prieto A; Sauer DB
    J Vis Exp; 2023 Sep; (199):. PubMed ID: 37843272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitubercular Agent Delamanid and Metabolites as Substrates and Inhibitors of ABC and Solute Carrier Transporters.
    Sasabe H; Shimokawa Y; Shibata M; Hashizume K; Hamasako Y; Ohzone Y; Kashiyama E; Umehara K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3497-508. PubMed ID: 27021329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of solute carrier transporters in regulating dendritic cell maturation and function.
    Shao L; Yang M; Sun T; Xia H; Du D; Li X; Jie Z
    Eur J Immunol; 2024 Feb; 54(2):e2350385. PubMed ID: 38073515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular modeling and ligand docking for solute carrier (SLC) transporters.
    Schlessinger A; Khuri N; Giacomini KM; Sali A
    Curr Top Med Chem; 2013; 13(7):843-56. PubMed ID: 23578028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The genetic landscape of the human solute carrier (SLC) transporter superfamily.
    Schaller L; Lauschke VM
    Hum Genet; 2019 Dec; 138(11-12):1359-1377. PubMed ID: 31679053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.